Meagan Jacoby, MD, PhD

Bone Marrow Transplant Specialist, Hematologist, Medical Oncologist

Meagan Jacoby

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108

Expertise & Training

Clinical Expertise

  • Bone marrow transplantation, leukemia, myelodysplastic syndrome

Primary Academic Title

Professor of Medicine, Division of Oncology, Section of Stem Cell Biology, WashU Medicine

Board Certification

  • 2009: American Board of Internal Medicine, Internal Medicine

Training

  • 2005 - 2007: Resident, Internal Medicine, Washington University, St. Louis, MO
  • 2007 - 2011: Fellow, Hematology and Oncology, Washington University, St. Louis, MO

Education

  • 2000: MD/PhD, Immunology, Washington University, St. Louis, MO

Research & Selected Publications

Research Publications

Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
Authors:

Gurnari C, Robin M, Adès L, one or more additional authors omitted Jacoby MA, one or more additional authors omitted Cazzola M

Journal & Year:

Blood | 2025

Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation
Authors:

Abboud R, Schroeder MA, Rettig MP, one or more additional authors omitted Jacoby MA, one or more additional authors omitted DiPersio JF

Journal & Year:

Blood | 2025

Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes
Authors:

Garcia JS, Platzbecker U, Odenike O, one or more additional authors omitted Jacoby MA, one or more additional authors omitted Garcia-Manero G

Journal & Year:

Blood | 2025

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025
Authors:

Greenberg PL, Stone RM, Abaza Y, one or more additional authors omitted Jacoby M, one or more additional authors omitted Hochstetler C

Journal & Year:

J Natl Compr Canc Netw | 2025

Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response
Authors:

Jacoby MA, Duncavage ED, Khanna A, one or more additional authors omitted Walter MJ

Journal & Year:

Leukemia | 2025